Jack V. Talley has been appointed president and chief executive officer and Enza Guagenti has been named chief financial officer of Actinium Pharmaceuticals, Inc. (API). Mr. Talley has more than 30 years of experience in marketing, drug development and regulatory matters. He was responsible for guiding two companies through the transition to becoming public reporting entities, Penwest Pharmaceuticals and EpiCept Corp., where he recently served as president and chief executive officer. He also ov...